Latest News & Features
Americas
US-based Supernus Pharmaceuticals has sued generic drug maker Par Pharmaceutical for allegedly infringing four patents covering its extended release anti-epileptic drug Trokendi XR (topiramate), the company announced on Friday. 20 January 2015
Americas
The US Supreme Court has vacated an appeals court judgment that invalidated a patent covering Teva’s blockbuster drug Copaxone (glatiramer acetate). 20 January 2015
Americas
The recent merger of law firms Edwards Wildman Palmer and Locke Lord has made way for the migration of an 18-strong team of life sciences lawyers to law firm Mintz Levin Cohn Ferris Glovsky and Popeo. 20 January 2015
Americas
Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US. 19 January 2015
Americas
California-based pharmaceutical company Depomed has revealed it will acquire the IP rights to Janssen Pharmaceuticals’ painkiller drug Nucynta (tapentadol) for $1.05 billion. 16 January 2015
Asia
Cipla has appealed against a decision by the Delhi High Court that blocked the generic drug maker from marketing copies of Novartis’s respiratory drug Onbrez (indacaterol) in India. 16 January 2015
Asia
The Indian Patent Office has rejected one of US drug maker Gilead’s patent applications to cover hepatitis C drug Sovaldi (sofosbuvir), in a decision that may decrease the blockbuster’s cost in the country. 16 January 2015
Asia
The Delhi High Court has issued a interim injunction stopping Indian generic drug maker Cipla from selling copies of Novartis’s respiratory drug Onbrez (indacaterol) in the country. 15 January 2015
Americas
The US Patent and Trademark Office has rejected several petitions that challenged a patent covering Jazz Pharmaceuticals’ narcolepsy drug Xyrem (sodium oxybate). 15 January 2015
Big Pharma
The Federal Court of Justice of Germany, the country’s highest court, has rejected an appeal from AstraZeneca in which the pharmaceutical company claimed that a patent used in its drug Seroquel XR (quetiapine) is valid. 14 January 2015